Suppr超能文献

镶嵌性过度生长综合征中脑回状结缔组织痣的分子异质性。

Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.

作者信息

Keppler-Noreuil Kim M, Burton-Akright Jasmine, Lindhurst Marjorie J, Shwetar Jasmine, Sapp Julie C, Darling Thomas, Biesecker Leslie G

机构信息

National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Department of Dermatology, Uniformed Services University of Health Sciences, Bethesda, Maryland 20814, USA.

出版信息

Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4). doi: 10.1101/mcs.a004036. Print 2019 Aug.

Abstract

The clinical diagnostic criteria for Proteus syndrome were defined before the discovery of the c.49G>A; p.(Glu17Lys) causal variant and used a combination of general and specific phenotypic attributes that could be combined to make a clinical diagnosis. The most heavily weighted specific criterion was the cerebriform connective tissue nevus (CCTN). Here, we describe two individuals with connective tissue nevi (CTNs) and some general attributes of Proteus syndrome who were found to have mosaic variants. CTNs on the soles of individuals with -related overgrowth typically exhibit thickening of the soft tissues with at most a wrinkled surface, but these two patients had firm plaques with ridges and furrows characteristic of CCTNs, which was histologically confirmed in one. These data show that CCTNs are not specific to Proteus syndrome and that clinicians should be cautious in diagnosing individuals with Proteus syndrome based on the CCTN alone. Rather, a complete evaluation should include careful assessment of other attributes of the diagnostic criteria and, whenever possible, genetic analysis of affected tissue.

摘要

变形综合征的临床诊断标准是在发现c.49G>A;p.(Glu17Lys)致病变异之前确定的,它使用了一般和特定的表型特征组合,这些特征可以结合起来进行临床诊断。权重最大的特定标准是脑回状结缔组织痣(CCTN)。在此,我们描述了两名患有结缔组织痣(CTN)以及一些变形综合征一般特征的个体,他们被发现存在嵌合变异。与相关过度生长个体足底的CTN通常表现为软组织增厚,表面最多有皱纹,但这两名患者有坚实的斑块,具有CCTN特有的嵴和沟,其中一名患者经组织学证实。这些数据表明,CCTN并非变形综合征所特有,临床医生仅根据CCTN诊断变形综合征患者时应谨慎。相反,全面评估应包括仔细评估诊断标准的其他特征,并尽可能对受影响组织进行基因分析。

相似文献

1
Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.
Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4). doi: 10.1101/mcs.a004036. Print 2019 Aug.
3
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
8
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people.
Cochrane Database Syst Rev. 2015 Apr 30;2015(4):CD009647. doi: 10.1002/14651858.CD009647.pub2.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.
Am J Med Genet A. 2022 Sep;188(9):2766-2771. doi: 10.1002/ajmg.a.62761. Epub 2022 Apr 20.
2
Phenotype and Surgical Treatment in a Case of Proteus Syndrome With Craniofacial and Oral Findings.
In Vivo. 2021 May-Jun;35(3):1583-1594. doi: 10.21873/invivo.12415.

本文引用的文献

1
c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report.
Clin Case Rep. 2018 Jun 2;6(7):1358-1363. doi: 10.1002/ccr3.1546. eCollection 2018 Jul.
2
Pathogenetic insights from quantification of the cerebriform connective tissue nevus in Proteus syndrome.
J Am Acad Dermatol. 2018 Apr;78(4):725-732. doi: 10.1016/j.jaad.2017.10.018. Epub 2017 Oct 16.
3
Quantifying survival in patients with Proteus syndrome.
Genet Med. 2017 Dec;19(12):1376-1379. doi: 10.1038/gim.2017.65. Epub 2017 Jun 29.
4
Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation.
Am J Med Genet A. 2016 Oct;170(10):2559-69. doi: 10.1002/ajmg.a.37758. Epub 2016 May 18.
5
Lack of mutation-histopathology correlation in a patient with Proteus syndrome.
Am J Med Genet A. 2016 Jun;170(6):1422-1432. doi: 10.1002/ajmg.a.37612. Epub 2016 Apr 26.
6
PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.
Am J Med Genet A. 2015 Feb;167A(2):287-95. doi: 10.1002/ajmg.a.36836. Epub 2014 Dec 31.
7
Cerebriform connective tissue nevus of lumbar.
J Dermatol. 2015 Feb;42(2):219-20. doi: 10.1111/1346-8138.12735. Epub 2014 Dec 16.
8
Myocardial fat overgrowth in Proteus syndrome.
Am J Med Genet A. 2015 Jan;167A(1):103-10. doi: 10.1002/ajmg.a.36773. Epub 2014 Nov 6.
9
Connective tissue nevi in children: institutional experience and review.
J Am Acad Dermatol. 2012 Nov;67(5):890-7. doi: 10.1016/j.jaad.2012.01.036. Epub 2012 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验